Clinical Trial: Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Stroke, Acute Ischemic
Study Type: INTERVENTIONAL
Official Title: The Feasibility, Safety and Efficacy of Y-3 Injection Through Skull Bone Marrow Bypassing Blood-brain Barrier in the Treatment of Acute Malignant Middle Cerebral Artery Infarction(SOLUTION)
Brief Summary:
The mortality of malignant middle cerebral artery infarction (mMCAI) is up to 80%, while current available treatment is limited.The purpose of this study is to explore the feasibility, safety and efficacy of Intracalvaria bone marrow injection of cytoprotective drug Y-3 in mMCAI patients with contradictions of reperfusion therapy or poor reperfusion outcome.
Read more